Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01159314 · ClinicalTrials.gov registry record · NA
Baerveldt Plate Area Comparison (BPAC)
A NA study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT01159314: Clinical Trial NA study, sponsored by Johns Hopkins University.
NCT01159314 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 69 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01159314, a NA study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
This research is being done to compare the safety and effectiveness of two sizes of the Baerveldt glaucoma implant. A Baerveldt glaucoma implant is one of the most common types of glaucoma operations performed. This procedure works by providing a route by which fluid can drain out of the eye to decrease the intraocular pressure. The Baerveldt implant does this by placing a tube into the eye which shunts aqueous fluid to a silicone plate which is attached to the sclera (white portion of the eye). It is this plate that comes in two different sizes (250 square millimeters and 350 square millimeters). Earlier studies have shown that larger plate sizes produce lower eye pressures but that they may also result in more complications. While both Baerveldt devices are currently in use and have been shown to be safe and effective, it is unclear if one is superior to the other. The purpose of this study is to see if one size of device works better with fewer complications.
Interventions
- PROCEDURE Baerveldt Device surgical Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2010-06 |
| Est. Completion | 2017-12-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01159314
The ClinicalTrials.gov registry entry for NCT01159314 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Baerveldt Device surgical Procedure is the first listed.
NCT01159314 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01159314 about?
NCT01159314 is a clinical study titled "Baerveldt Plate Area Comparison (BPAC)". This research is being done to compare the safety and effectiveness of two sizes of the Baerveldt glaucoma implant. A Baerveldt glaucoma implant is one of the most common types of glaucoma operations performed. This procedure works by providing a route by which fluid can drain out of the eye to dec...
What is the current status of trial NCT01159314?
This trial is currently terminated. It is a NA study. The enrollment target is 69 participants. The study started on 2010-06. Estimated completion is 2017-12-04.
What interventions are being tested in trial NCT01159314?
The interventions under investigation include: Baerveldt Device surgical Procedure (PROCEDURE).
Who is sponsoring clinical trial NCT01159314?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.